Glaxosmithkline Likely to Skirt Charges in China, but Not the Executives
SHANGHAI – Authorities are reportedly set on charging London-based Glaxosmithkline plc’s (GSK) Chinese executives on charges of bribery and corruption following initial claims by the Chinese police in July. This would leave the beleaguered GSK free from corporate criminal prosecution, but still facing potential administrative fines, investigations from anti bribery authorities in the U.S. and the UK and a sharp decline in revenues in China.
Outside of the US
In the U.S. and Canada: +1-800-336-4474
Outside the U.S.: +44-203-684-1796
Hours: Monday - Friday, 8:00am - 6:00 pm EST